Brachytherapy Training Program

Radiation oncologists, medical physicists, administrators, and radiation therapists interested in implementing brachytherapy into clinical practice are encouraged to attend this program.

Led by Kevin Albuquerque, M.D., Professor, and Brian Hrycushko, Ph.D., Associate Professor, the primary focus of this course is to help oncology professionals in academic, community, and private centers learn about and better understand the proper implementation of a viable and effective brachytherapy treatment practice.

This course aims to introduce state-of-the-art HDR brachytherapy techniques and best-practice guidelines though a combination of didactic lectures, live/video procedure/equipment demonstrations, and hands-on training sessions.

Accreditation

The University of Texas Southwestern Medical Center designates this live activity for a maximum of 12.0 AMA PRA Category 1 credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Society of Radiologic Technologists designates this live activity for Category A credit(s). Therapists should only claim credit commensurate with the extent of participation in the activity.

The Commission on Accreditation of Medical Physics Educational Programs designates this live activity for a maximum of 17 CAMPEP Education credit(s). Medical physicists should only claim credit commensurate with the extent of participation in the activity.

Program Directors and Presenters

Directors: Kevin Albuquerque, M.D., and Brian Hrycushko, Ph.D.

Physicists: Thomas Banks, Ph.D., and Zohaib Iqbal, Ph.D.

Register

If your institution has an active Elekta contract with available education credits to be utilized for this training course, there will be no fee assessed at this time. Our training coordinator will contact Elekta to confirm contract eligibility on your behalf before moving forward with registration.

Disclaimer: This training program has been planned to be well-balanced and objective in discussion of comparative treatment regimens and the symposium format allows for the free scientific exchange of ideas. Information and opinions offered by the speakers represent their viewpoints. Conclusions drawn by the audience should be derived from careful consideration of all available scientific information.